News
Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback